Memory T cells' balance of granzyme K and granzyme B tracks with how healthily people age

Only the first of the study's three analyses counts cells directly. In the 2,600-person group, the team compared each person's balance of granzyme K- and granzyme B-making memory T cells with the immune conditions that person had ^[3]. Granzymes are the proteins these cells use to kill infected cells ^[10].

The 17 years of follow-up come from UK Biobank, a database of health data from U.K. adults ^[9]. There, granzyme B cell levels were predicted from blood proteins. The predictor was a signature the team built from 329 people who gave both immune cells and protein samples ^[4][5]. The roughly 48,000 participants it was applied to outnumber that group about 146 to one ^[16]. Any gap between the signature and real cell counts carries into every Biobank result.

Artyomov, a co-author and immunologist at Washington University in St. Louis, told Live Science the balance could one day be a test of "whether you're on the right trajectory of aging or not" ^[2][17]. I think the evidence supports the ratio as a candidate marker for that job. Its long-range case still rests on the protein stand-in. Live Science's report does not give effect sizes, and it does not say whether the signature predicts more than age alone does ^[5].

Artyomov also warned against reading the link as cause. "This observation might be just a consequence, not a cause of the disease," he said ^[7]. In the 2,600-person data, a chronic immune condition could itself shift a person's cell balance, and the association would look the same ^[3].

The team's earlier work makes the human result harder to read. In old lab mice, granzyme K-making cells built up in several tissues and were linked to inflammation, and older adults' blood showed the same rise in granzyme K cells ^[11]. In the new study, people whose cells lean toward granzyme K tend to age in better health ^[1]. Claire Gustafson, an immunologist at the Allen Institute who was not involved, called the species difference "underappreciated" ^[14]. When comparing these cells in mice and humans, "we're not looking at apples to apples," she said ^[14].

"I think that's really exciting," Gustafson said of the results ^[13]. "It highlights there's potentially some novel biology that we haven't really observed before," she said ^[15]. She also said immune features vary across human populations, and that a "true understanding of universal immune health" needs more data from them ^[8].